KeithDavidEatonMD

PubMed

• Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.
  Joseph B Hiatt, Anna-Lisa Doebley, Henry U Arnold, Mohamed Adil, Holly Sandborg, Thomas W Persse, Minjeong Ko, Feinan Wu, Alvaro Quintanal Villalonga, Rafael Santana-D...> ;Science Advances. 2024 Apr 12
• Central Line Patency: Management With Normal Saline Flushes for Adult Patients With Cancer.
  Grace Baek, Phuong Huynh, Terri Cunningham, Simran Ghuman, Keith D Eaton> ;Clinical Journal of Oncology Nursing. 2023 May 18
• 1 citations
  Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions.
  Mark Edward Jao, Amy Ly Indorf, Eve-Michelle Segal, Abby Miske, Keith David Eaton, Trisha Marsolini, Simran Ghuman> ;Journal of Oncology Pharmacy Practice. 2024 Jan 1
• 1 citations
  Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study.
  Melissa L Johnson, James Strauss, Manish R Patel, Edward B Garon, Keith D Eaton, Tavette Neskorik, Josée Morin, Richard Chao, Balazs Halmos> ;Clinical Lung Cancer. 2023 May 1
• 1 citations
  Development of Neuropathic Arthropathy With Entrectinib: Case Report.
  Nicholas P Giustini, Hanna Oh, Keith D Eaton> ;JTO Clinical and Research Reports. 2022 Nov 1
• 16 citations
  First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
  Todd Bauer, Byong Chul Cho, Rebecca Heist, Lyudmila Bazhenova, Theresa Werner, Sanjay Goel, Dong-Wan Kim, Douglas Adkins, Richard D Carvajal, Ajjai Alva, Keith Eaton, ...> ;Investigational New Drugs. 2022 Oct 1
• 2 citations
  Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.
  Perrin E Romine, Qin Sun, Catherine Fedorenko, Li Li, Mariel Tang, Keith D Eaton, Bernardo H L Goulart, Renato G Martins> ;JCO Oncology Practice. 2022 Jun 1
• 7 citations
  Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
  Cameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, Rafael Santana-Davila, Victoria Hwang, Christina S Baik, Sylvia Lee, Brittany Barber, Neal D Futran, Jeffrey J Hoult...> ;Cancer Medicine. 2022 Nov 1
• High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
  Cameron Chalker, Rafael Santana-Davila, Jenna M. Voutsinas, Qian Vicky Wu, Victoria Hwang, Christina S. Baik, Sylvia Lee, Brittany Barber, Neal D. Futran, Jeffrey J. H...> ;Journal of Palliative Medicine. 2021 Nov 30
• 2 citations
  Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-...
  Stephen R Bowen, Daniel S Hippe, Hannah M Thomas, Balukrishna Sasidharan, Paul D Lampe, Christina S Baik, Keith D Eaton, Sylvia Lee, Renato G Martins, Rafael Santana-D...> ;Advances in Radiation Oncology. 2021 Nov 21
• Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
  Perrin E. Romine, Jenna M. Voutsinas, Vicky Wu, Micah Tratt, Jay J. Liao, Upendra Parvathaneni, Brittany Barber, Jasjit K. Dillon, Neal Futran, Jeffrey J. Houlton, Geo...> ;Oral Oncology. 2021 Nov 19
• Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.
  Keith D. Eaton, Perrin E. Romine, Renato G. Martins, Antoine Leblond, Laurie L Carr, Hubert J Vesselle> ;Cureus. 2021 Oct 15
• 1 citations
  Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer
  Cristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D. Eaton, Renato G. Martins, Scott D. Ramsey, Bernardo H. L. Goulart> ;JCO Oncology Practice. 2021 Aug 10
• A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy.
  Christina S. Baik, Sylvia Lee, Kitty Cook, Sarah G. Wallace, Rebecca Wood, Rafael Santana-Davila, Laura Q.M. Chow, Cristina P. Rodriguez, Keith D. Eaton, Renato G. Mar...> ;Cancer Treatment and Research Communications. 2021 Jan 1
• 3 citations
  Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
  Cristina Merkhofer, Keith D. Eaton, Renato G. Martins, Scott D. Ramsey, Bernardo H. L. Goulart> ;Clinical Lung Cancer. 2021 Apr 22
• 5 citations
  A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
  Viswam S. Nair, Keith D. Eaton, A. McGarry Houghton> ;Respiratory Medicine Case Reports. 2021 Jan 1
• 37 citations
  MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity.
  Eli Grunblatt, Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P. Norton, Yamini M. Ohol, Paul Leger, Joseph B. Hiatt, Emily Eastwood, Rhiana Thomas, Ali H. Ibrahim, Deshui J...> ;Genes & Development. 2020 Sep 1
• 22 citations
  Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
  Sara Bedrose, Kevin C. Miller, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D. Eaton, Jeffrey Yorio, Davey B Daniel, Matthew Campbell, Keith C. Bibl...> ;Journal for Immunotherapy of Cancer. 2020 Jul 1
• 101 citations
  A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
  Cristina P. Rodriguez, Qian Vicky Wu, Jenna M. Voutsinas, Jonathan R. Fromm, Xiuyun Jiang, Venu G. Pillarisetty, Sylvia Lee, Rafael Santana-Davila, Bernardo H. L. Goul...> ;Clinical Cancer Research. 2020 Feb 15
• Aldosterone-Secreting Adrenocortical Carcinoma Presenting With Cardiac Arrest
  Nicole K. Zern, Keith D. Eaton, Mara Y. Roth> ;Journal of the Endocrine Society. 2019 Jun 12
• 111 citations
  Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
  Arnaud Augert, Emily Eastwood, Ali H. Ibrahim, Nan Wu, Eli Grunblatt, Ryan Basom, Denny Liggitt, Keith D. Eaton, Renato G. Martins, John T. Poirier, Charles M. Rudin, ...> ;Science Signaling. 2019 Feb 5
• 5 citations
  Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of ou...
  Perrin E. Romine, Renato G. Martins, Keith D. Eaton, Douglas E. Wood, Fatemeh Behnia, Bernardo H. L. Goulart, Michael S. Mulligan, Sarah G. Wallace, Elizabeth M. Kell,...> ;BMC Cancer. 2019 Jan 14
• Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia.
  Perrin E. Romine, Keith D. Eaton, Kelly G. Paulson, Rouba Hadi, Douglas S. Paauw> ;The American Journal of Medicine. 2019 Jan 1
• 7 citations
  Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 tr...
  Margaret K. Guerriero, Mary W. Redman, Kelsey Baker, Renato G. Martins, Keith D. Eaton, Laura Qm Chow, Rafael Santana-Davila, Christina S. Baik, Bernardo H. L. Goulart...> ;Cancer. 2018 Jul 1
• 28 citations
  Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility
  Keith D. Eaton, Perrin E. Romine, Gary E. Goodman, Mark D. Thornquist, Matt J. Barnett, Effie W. Petersdorf> ;Journal of Thoracic Oncology. 2018 May 1
• Join now to see all